KINIKSA PHARMACEUTICALS, LTD. Restricted Stock AgreementRestricted Stock Agreement • February 25th, 2021 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 25th, 2021 Company IndustryAGREEMENT made this 18 day of September, 2015, between Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company (the "Company"), and Thomas Beetham (the "Founder").
DESKTOP METAL, INC. Restricted Stock AgreementRestricted Stock Agreement • October 15th, 2020 • Trine Acquisition Corp. • Computer peripheral equipment, nec • Delaware
Contract Type FiledOctober 15th, 2020 Company Industry JurisdictionAGREEMENT made this 18th day of September, 2015, between Desktop Metal, Inc., a Delaware corporation (the “Company”), and Ric Fulop (the “Founder”).
KINIKSA PHARMACEUTICALS, LTD. Restricted Stock AgreementRestricted Stock Agreement • January 28th, 2019 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations
Contract Type FiledJanuary 28th, 2019 Company IndustryAGREEMENT made this 16 day of September, 2015, between Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company (the “Company”), and Sanj K. Patel (the “Founder”).
KINIKSA PHARMACEUTICALS, LTD. Restricted Stock AgreementRestricted Stock Agreement • January 28th, 2019 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations
Contract Type FiledJanuary 28th, 2019 Company IndustryAGREEMENT made this 18 day of September, 2015, between Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company (the “Company”), and Stephen Mahoney (the “Founder”).
KINIKSA PHARMACEUTICALS, LTD. Restricted Stock AgreementRestricted Stock Agreement • December 13th, 2018 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations
Contract Type FiledDecember 13th, 2018 Company IndustryAGREEMENT made this 16 day of September, 2015, between Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company (the “Company”), and Sanj K. Patel (the “Founder”).
KINIKSA PHARMACEUTICALS, LTD. Restricted Stock AgreementRestricted Stock Agreement • December 13th, 2018 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations
Contract Type FiledDecember 13th, 2018 Company IndustryAGREEMENT made this 18 day of September, 2015, between Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company (the “Company”), and Stephen Mahoney (the “Founder”).
OVASCIENCE, INC. Amended and Restated Restricted Stock AgreementRestricted Stock Agreement • April 11th, 2012 • OvaScience, Inc. • Delaware
Contract Type FiledApril 11th, 2012 Company JurisdictionAGREEMENT made this 29th day of March, 2012, between OvaScience, Inc., a Delaware corporation (the “Company”), Richard Aldrich (“Aldrich”) and the Richard H. Aldrich Irrevocable Trust of 2011 (the “Trust”, and, together with Aldrich, the “Founder”) . This agreement amends and restates in its entirety the Restricted Stock Agreement, dated April 7, 2011, between the Company (formerly known as Ovastem, Inc.) and Aldrich (the “Prior Restricted Stock Agreement”). In connection with the transfer of shares of stock subject to the Prior Restricted Stock Agreement from Aldrich to the Trust on December 30, 2011, the Trust agreed to become party to and bound by the Prior Restricted Stock Agreement.
OVASCIENCE, INC. Amended and Restated Restricted Stock AgreementRestricted Stock Agreement • April 11th, 2012 • OvaScience, Inc. • Delaware
Contract Type FiledApril 11th, 2012 Company JurisdictionAGREEMENT made this 29th day of March, 2012, between OvaScience, Inc., a Delaware corporation (the “Company”), (the “Founder”). This agreement amends and restates in its entirety the Restricted Stock Agreement, dated April 7, 2011, between the Company (formerly known as Ovastem, Inc.) and the Founder (the “Prior Restricted Stock Agreement”).
OVASCIENCE, INC. Amended and Restated Restricted Stock AgreementRestricted Stock Agreement • April 11th, 2012 • OvaScience, Inc. • Delaware
Contract Type FiledApril 11th, 2012 Company JurisdictionAGREEMENT made this 29th day of March, 2012, between OvaScience, Inc., a Delaware corporation (the “Company”), (the “Founder”). This agreement amends and restates in its entirety the Restricted Stock Agreement, dated April 7, 2011, between the Company (formerly known as Ovastem, Inc.) and the Founder (the “Prior Restricted Stock Agreement”).